Moolec Science SA (NASDAQ:MLEC – Get Free Report) saw a significant decline in short interest in July. As of July 15th, there was short interest totaling 9,414 shares, a decline of 48.9% from the June 30th total of 18,435 shares. Currently, 1.6% of the company’s stock are short sold. Based on an average daily volume of 4,381 shares, the days-to-cover ratio is currently 2.1 days.
Moolec Science Stock Down 3.6%
MLEC traded down $0.26 during trading on Tuesday, hitting $7.10. The company had a trading volume of 4,192 shares, compared to its average volume of 703,744. Moolec Science has a 1-year low of $3.08 and a 1-year high of $53.40. The company has a debt-to-equity ratio of 0.79, a current ratio of 0.15 and a quick ratio of 0.08. The company has a market cap of $5.18 million, a PE ratio of -0.22 and a beta of 0.26. The business has a 50-day moving average of $7.50 and a 200-day moving average of $7.99.
Moolec Science (NASDAQ:MLEC – Get Free Report) last issued its quarterly earnings results on Thursday, May 14th. The company reported $47.49 EPS for the quarter. The company had revenue of $2.62 million for the quarter.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on Moolec Science
Institutional Investors Weigh In On Moolec Science
An institutional investor recently bought a new position in Moolec Science stock. Citadel Advisors LLC acquired a new position in Moolec Science SA (NASDAQ:MLEC – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned 0.90% of Moolec Science at the end of the most recent reporting period. 0.07% of the stock is currently owned by institutional investors and hedge funds.
Moolec Science Company Profile
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
Further Reading
- Five stocks we like better than Moolec Science
- 5 Space Stocks Face a Brutal Correction: Which Ones Are Still Buys?
- Whirlpool’s Report May Show How Frozen the Housing Market Really Is
- 3 Stocks Standing Out and 2 Losing Momentum as the Tech Rally Cracks
- 5 AI Stocks Are Pulling Back—Which Growth Catalysts Still Look Strongest?
Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.
